日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen Bacillus anthracis and Its Type II Topoisomerases

新型细菌拓扑异构酶抑制剂OSUAB-0284对生物威胁病原体炭疽杆菌及其II型拓扑异构酶的活性

Mann, Chelsea A; Halasohoris, Stephanie A; Gray, Annette M; Chua, Jennifer; Spencer, Jade L; Curry, Bobby J; Babyak, Ashley L; Klimko, Christopher P; Cote, Christopher K; West, Jason S; Mitton-Fry, Mark J; Meinig, J Matthew; Osheroff, Neil

Virulence of Burkholderia pseudomallei ATS2021 Unintentionally Imported to United States in Aromatherapy Spray

意外通过芳香疗法喷雾剂进口到美国的类鼻疽伯克霍尔德菌 ATS2021 的毒力

Cote, Christopher K; Mlynek, Kevin D; Klimko, Christopher P; Biryukov, Sergei S; Mou, Sherry; Hunter, Melissa; Rill, Nathaniel O; Dankmeyer, Jennifer L; Miller, Jeremey A; Talyansky, Yuli; Davies, Michael L; Meinig, J Matthew; Halasohoris, Stephanie A; Gray, Anette M; Spencer, Jade L; Babyak, Ashley L; Hourihan, M Kelly; Curry, Bobby J; Toothman, Ronald G; Ruiz, Sara I; Zeng, Xiankun; Ricks, Keersten M; Clements, Tamara L; Douglas, Christina E; Ravulapalli, Suma; Stefan, Christopher P; Shoemaker, Charles J; Elrod, Mindy G; Gee, Jay E; Weiner, Zachary P; Qiu, Ju; Bozue, Joel A; Twenhafel, Nancy A; DeShazer, David

Efficacy of Delafloxacin against the Biothreat Pathogen Burkholderia pseudomallei

德拉沙星对生物威胁病原体类鼻疽伯克霍尔德菌的疗效

McCurdy, Sandra; Duffy, Erin; Hickman, Mark; Halasohoris, Stephanie; Zumbrun, Steven D

In Vitro and In Vivo Characterization of Tebipenem (TBP), an Orally Active Carbapenem, against Biothreat Pathogens

口服活性碳青霉烯类抗生素替比培南(TBP)对抗生物威胁病原体的体外和体内特性研究

Clayton, Nicholas P; Jain, Akash; Halasohoris, Stephanie A; Pysz, Lisa M; Lembirik, Sanae; Zumbrun, Steven D; Kane, Christopher D; Hackett, Michael J; Pfefferle, Denise; Smiley, M Autumn; Anderson, Michael S; Heine, Henry; Meister, Gabriel T; Pucci, Michael J

In vitro and in vivo activity of GT-1, a novel siderophore cephalosporin, and GT-055, a broad-spectrum β-lactamase inhibitor, against biothreat and ESKAPE pathogens

GT-1(一种新型铁载体头孢菌素)和 GT-055(一种广谱β-内酰胺酶抑制剂)对生物威胁病原体和ESKAPE病原体的体外和体内活性

Halasohoris, Stephanie A; Scarff, Jennifer M; Pysz, Lisa M; Lembirik, Sanae; Lemmon, Margaret M; Biek, Donald; Hannah, Brendan; Zumbrun, Steven D; Panchal, Rekha G

Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against Yersinia pestis Infection in a Bubonic Plague Model

在鼠疫模型中,抗 Lcr V 单克隆抗体的结合位点比针对鼠疫耶尔森菌感染的被动保护的亲和力和亲和力更为关键

Kei Amemiya, Jennifer L Dankmeyer, Sarah L Keasey, Sylvia R Trevino, Michael M Wormald, Stephanie A Halasohoris, Wilson J Ribot, David P Fetterer, Christopher K Cote, Patricia L Worsham, Jeffrey J Adamovicz, Robert G Ulrich

Demonstration of the broad spectrum in vitro activity of finafloxacin against pathogens of biodefence interest

体外实验证实芬那沙星对具有生物防御意义的病原体具有广谱活性

Barnes, Kay B; Zumbrun, Steven D; Halasohoris, Stephanie A; Desai, Purvi D; Miller, Lynda L; Richards, Mark I; Russell, Paul; Bentley, Christine; Harding, Sarah V

Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens in vitro and in vivo

富含脯氨酸的抗菌肽与小分子抗生素在体外和体内对特定革兰氏阴性病原体的协同作用

Otvos, Laszlo Jr; Ostorhazi, Eszter; Szabo, Dora; Zumbrun, Steven D; Miller, Lynda L; Halasohoris, Stephanie A; Desai, Puvi D; Int Veldt, Sharon M; Kraus, Carl N

In Vitro Antibiotic Susceptibilities of Francisella tularensis Determined by Broth Microdilution following CLSI Methods

采用CLSI方法,通过肉汤微量稀释法测定土拉弗朗西斯菌的体外抗生素敏感性

Heine, Henry S; Miller, Lynda; Halasohoris, Stephanie; Purcell, Bret K

In Vitro and In Vivo Activity of Omadacycline against Two Biothreat Pathogens, Bacillus anthracis and Yersinia pestis

奥马环素对两种生物威胁病原体(炭疽杆菌和鼠疫耶尔森菌)的体外和体内活性

Steenbergen, Judith; Tanaka, S Ken; Miller, Lynda L; Halasohoris, Stephanie A; Hershfield, Jeremy R